Breaking News, Collaborations & Alliances

bioMérieux, JMI Laboratories Partner to Fight Antimicrobial Resistance

bioMérieux will assess AST/AES results and validate against evolving global antimicrobial susceptibility data collected through the JMI-led SENTRY program.

bioMérieux and JMI Laboratories (JMI) entered a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR. “As global organizations committed to world-class antimicrobial stewardship as a way to combat AMR, we’ve partnered to establish and address contemporary issues of antimicrobial resistance and ensure accurate AST results to guide effective treat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters